Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
2,650 adverse event reports (+66% vs 2022)
In 2023, 2,650 adverse event reports were filed for HPV (Gardasil 9) in VAERS. This represents 9.8% of all 26,909 reports for this vaccine.
Of these reports, 5 mentioned death, 39 involved hospitalization, 154 required ER visits, and 54 reported disability.
Compared to the average of 2,323 reports per year for this vaccine, 2023 was above average (+14%).
In 2023, reporting for HPV (Gardasil 9) was within typical ranges. As always, VAERS data reflects reports filed, not confirmed adverse events. Trends should be interpreted alongside vaccination volume and population health data.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.